Live from the NIH registry
Studies recruiting near Albany right now
Top 25 of 202 recruiting studies, sorted by proximity — each links to its official registry page
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
Ovarian Carcinoma
N/A
Interventional 1,956 participants sought
Women's Cancer Care Associates LLC — Albany, New York (2.4 mi)
· Sponsor: NRG Oncology
Registry of Patients With Brain Tumors Treated With STaRT (GammaTiles)
Brain Tumor, Recurrent, Brain Tumor
N/A
Observational 600 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: GT Medical Technologies, Inc.
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
Alzheimer's Disease
Phase 3
Interventional 586 participants sought
Neurological Associates Albany — Albany, New York (2.4 mi)
· Sponsor: Bristol-Myers Squibb
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Breast Neoplasms, Neoplasm Metastasis
Phase 3
Interventional 800 participants sought
NYOH Albany Cancer Center — Albany, New York (2.4 mi)
· Sponsor: Eli Lilly and Company
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study
Transitional Cell Cancer of Renal Pelvis and Ureter
Phase 3
Interventional 100 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: Steba Biotech S.A.
A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis
Recurrent Langerhans Cell Histiocytosis, Refractory Langerhans Cell Histiocytosis
Phase 2
Interventional 48 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: NRG Oncology
Vibrator Use to Improve Sexual and Pelvic Floor Function Among Urogynecology Patients
Pelvic Floor Dysfunction, Sexual Dysfunction Female
N/A
Interventional 84 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Albany Medical College
A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015)
Non-small Cell Lung Cancer
Phase 3
Interventional 310 participants sought
New York Oncology Hematology P.C ( Site 9000) — Albany, New York (2.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
Triple Negative Breast Cancer
Phase 3
Interventional 1,514 participants sought
New York Oncology Hematology (NYOH) — Amsterdam, New York (27.3 mi)
· Sponsor: Gilead Sciences
DRAIN: DRainage in Acute Decompensated Heart faIlure With Pleural effusioNs
Congestive Heart Failure(CHF), Pleural Effusion Due to Congestive Heart Failure
N/A
Interventional 216 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Albany Medical College
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Castration Levels of Testosterone, Metastatic Prostatic Adenocarcinoma
Phase 3
Interventional 1,273 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Investigate the Efficacy and Safety of Apraglutide Compared With Placebo in Adult Participants With Short Bowel Syndrome Associated With Intestinal Failure (SBS-IF)
Short Bowel Syndrome (SBS), SBS Associated With Intestinal Failure (SBS-IF)
Phase 3
Interventional 124 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: VectivBio AG
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma
Low Grade Astrocytoma, Low Grade Glioma
Phase 3
Interventional 170 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
Hypothyroidism
Phase 2, Phase 3
Interventional 2,800 participants sought
Albany Medical College- Endocrinology Washington Extension /ID# 256794 — Albany, New York (2.4 mi)
· Sponsor: AbbVie
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 3
Interventional 286 participants sought
New York Nephrology and Dialysis Access Surgery, PC — Clifton Park, New York (13.8 mi)
· Sponsor: Boehringer Ingelheim
Safety and Efficacy of J147 in Acute Ischemic Stroke
Acute Ischemic Stroke
Phase 2
Interventional 196 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Abrexa Pharmaceuticals, Inc.
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Capital Cardiology Associates_Albany — Albany, New York (2.4 mi)
· Sponsor: Novo Nordisk A/S
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
Type 1 Diabetes Mellitus With Hypoglycemia
Phase 2
Interventional 186 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: Zucara Therapeutics Inc.
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
New York Oncology Hematology, P.C. ( Site 0069) — Albany, New York (2.4 mi)
· Sponsor: Merck Sharp & Dohme LLC
Study of Denikitug (GS-1811) Given Alone or With Nivolumab or Chemotherapy in Adults With Metastatic Gastric, Gastroesophageal Junction (GEJ), and Esophageal Adenocarcinomas
HER2-negative, Gastroesophageal Junction
Phase 2
Interventional 120 participants sought
New York Oncology Hematology — Albany, New York (2.4 mi)
· Sponsor: Gilead Sciences
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Huntington's Disease
N/A
Observational 35,000 participants sought
Albany Medical College — Albany, New York (2.4 mi)
· Sponsor: CHDI Foundation, Inc.
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
High Grade Osteosarcoma, Localized Osteosarcoma
Phase 2, Phase 3
Interventional 1,122 participants sought
Albany Medical Center — Albany, New York (2.4 mi)
· Sponsor: National Cancer Institute (NCI)